Patterns of reporting of influenza and pertussis vaccination during pregnancy to the Australian Immunisation Register, 2022
Preprint
Abstract
Objectives Timely, accurate reporting of pregnancy vaccination coverage is key to evaluating pregnancy immunisation programs. We compared influenza and pertussis vaccination reporting on the New South Wales (NSW) Perinatal Data Collection (PDC) and the Australian Immunisation Register (AIR), to understand coverage, reporting, timing of vaccination and provider type. Design Retrospective population-based cohort study. Setting People giving birth at ≥20-weeks gestation (2017–2022) in the NSW PDC, linked to AIR-reported influenza and pertussis vaccinations. Main outcome measures Influenza and pertussis coverage according to 1) the PDC and 2) linked AIR records, and agreement between data sources by year (influenza: 2021–2022, pertussis: 2017–2022) and selected characteristics (2022). Description of provider type and timing for vaccinations reported to the AIR (2022). Results PDC-reported influenza and pertussis coverage peaked in 2020 (influenza: 58.8% (52,940/90,091), pertussis: 79.0% (71,169/90,091)), decreasing thereafter (influenza: 49.1% (43,744/89,112), pertussis: 77.6% (69,129/89,112) in 2022). Influenza and pertussis vaccination coverage as reported to the AIR increased from 34.7% (33,611/96,789) in 2021 to 44.8% (39,935/89,112) in 2022 and 24.4% (22,857/93,582) in 2017 to 51.6% (46,009/89,112) in 2022, respectively. Agreement between AIR and PDC improved over time, but remained suboptimal (influenza: 75.5%, pertussis: 56.6% in 2022). AIR and PDC agreement differed most by antenatal care model, particularly for pertussis vaccinations. In 2022, of pregnancy vaccinations reported to the AIR, >75% were provided in general practices. Co- administration occurred infrequently (8.8%). Conclusions Despite mandated reporting to the AIR, there was significant underreporting of pregnancy vaccinations to the AIR as compared with the NSW PDC. National collection of accurate and timely data on pregnancy vaccination coverage is needed to monitor vaccine uptake, and identify and monitor strategies to improve uptake, particularly with the new pregnancy RSV vaccine program in 2025. We identified co-administration as a potential strategy to improve influenza vaccination coverage during pregnancy.Keywords
This publication has 12 references indexed in Scilit:
- Maternal Vaccine Effectiveness Against Influenza-Associated Hospitalizations and Emergency Department Visits in InfantsJAMA Pediatrics, 2024
- Coverage and predictors of influenza and pertussis vaccination during pregnancy: a whole of population-based studyVaccine, 2023
- Inequity of antenatal influenza and pertussis vaccine coverage in Australia: the Links2HealthierBubs record linkage cohort study, 2012–2017BMC Pregnancy and Childbirth, 2023
- How accurately does the Australian Immunisation Register identify children overdue for vaccine doses? A national cross-sectional studyCommunicable Diseases Intelligence, 2022
- Preventing severe influenza in Australian infants: Maternal influenza vaccine effectiveness in the PAEDS-FluCAN networks using the test-negative designVaccine, 2022
- Maternal Vaccination and Infant Influenza and PertussisPediatrics, 2021
- Children overdue for immunisation: a question of coverage or reporting? An audit of the Australian Immunisation RegisterAustralian and New Zealand Journal of Public Health, 2019
- Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010–2016Clinical Infectious Diseases, 2018
- Effectiveness of Maternal Influenza Immunization in Mothers and InfantsNew England Journal of Medicine, 2008
- Immunisation coverage in Australia corrected for under‐reporting to the Australian Childhood Immunisation RegisterAustralian and New Zealand Journal of Public Health, 2003